[HTML][HTML] A prospective study showing an excellent response of patients with low-risk differentiated thyroid cancer who did not undergo radioiodine remnant ablation …
CCPS Janovsky, RMB Maciel… - European thyroid …, 2016 - etj.bioscientifica.com
Objectives: To prospectively evaluate the outcome of patients with low-risk papillary thyroid
carcinoma treated with total thyroidectomy (TT) who did not undergo radioiodine remnant …
carcinoma treated with total thyroidectomy (TT) who did not undergo radioiodine remnant …
Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation
Context: There is much debate surrounding the choice of which patient should be submitted
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study
V Ilera, I Califano, A Cavallo, E Faure, A Vázquez… - Endocrine, 2023 - Springer
Background In patients with low-risk differentiated thyroid cancer (DTC), remnant ablation
with radioiodine (RA) after total thyroidectomy (TT) is controversial. No benefits have been …
with radioiodine (RA) after total thyroidectomy (TT) is controversial. No benefits have been …
Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation
PW Rosario, AFC Mineiro Filho, BSS Prates, LCO Silva… - Thyroid, 2012 - liebertpub.com
Background: Stimulated thyroglobulin (Tg)≤ 1 ng/mL after thyroidectomy (after L-thyroxine
[L-T4] withdrawal or administration of recombinant human thyrotropin [rhTSH]) has been …
[L-T4] withdrawal or administration of recombinant human thyrotropin [rhTSH]) has been …
Effectiveness of reduced radioiodine activity for thyroid remnant ablation after total thyroidectomy in patients with low to intermediate risk differentiated thyroid …
A Todica, S Haidvogl, WP Fendler… - Nuklearmedizin …, 2017 - thieme-connect.com
Aim: To compare the success rates of radioiodine therapy (RIT) for thyroid remnant ablation
(TRA) after the administration of a high-standard activity (3700 MBq; 100 mCi) to a lower …
(TRA) after the administration of a high-standard activity (3700 MBq; 100 mCi) to a lower …
[HTML][HTML] 99mTc-pertechnetate scintigraphy predicts successful postoperative ablation in differentiated thyroid carcinoma patients treated with low radioiodine activities
L Giovanella, G Paone, T Ruberto… - Endocrinology and …, 2019 - ncbi.nlm.nih.gov
Background Postoperative routine radioiodine (RAI) treatment is currently debated for
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low 131 …
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low 131 …
Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human …
R Elisei, M Schlumberger, A Driedger… - The Journal of …, 2009 - academic.oup.com
Background: We previously demonstrated comparable thyroid remnant ablation rates in
postoperative low-risk thyroid cancer patients prepared for administration of 3.7 GBq 131I …
postoperative low-risk thyroid cancer patients prepared for administration of 3.7 GBq 131I …
[HTML][HTML] Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
PW Rosario, GF Mourão - Archives of Endocrinology and Metabolism, 2016 - SciELO Brasil
Objective This prospective study evaluated the recurrence rate in low-risk patients with
papillary thyroid cancer (PTC) who presented slightly elevated thyroglobulin (Tg) after …
papillary thyroid cancer (PTC) who presented slightly elevated thyroglobulin (Tg) after …
Radioiodine remnant ablation in differentiated thyroid cancer after combined endogenous and exogenous TSH stimulation
A Vrachimis, O Schober… - Nuklearmedizin …, 2012 - thieme-connect.com
Aim: Radioiodine remnant ablation (RRA) after (near-) total thyroidectomy (TE) is a key
element in patients with differentiated thyroid cancer (DTC). The use of exogenous TSH …
element in patients with differentiated thyroid cancer (DTC). The use of exogenous TSH …
Low-activity (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low-risk …
M Chianelli, V Todino, FM Graziano… - European Journal of …, 2009 - academic.oup.com
Objective (a) To compare the efficacy of low-activity (2 GBq; 54 mCi) 131I ablation using l-
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …
thyroxine withdrawal or rhTSH stimulation, and (b) to assess the influence of thyroid …